Published in Cancer Weekly, June 21st, 2005
According to recent research published in the Head and Neck - Journal for the Sciences and Specialties of the Head and Neck, "hyperbaric oxygen (HBO2 ) is used to promote healing in irradiated tissues, but concern persists about the possibility that it may promote residual tumor growth."
"The tumor growth of SQ20B and Detroit 562 head and neck squamous cell carcinoma xenografts were studied after single-dose irradiation and 5x/week HBO2 treatment at 2.4 atm absolute for 90 minutes. The effect of HBO2 treatment on tumor hypoxia and vasculature...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.